🔗 Share this article

A shadow market for unapproved slimming drugs is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.

Experimental Drug Acquiring Traction Online

Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are encouraged to message these profiles privately for supplier links, while also receiving discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering substances of uncertain source.

Some professionals stated the demand for retatrutide could be linked to the rising cost of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and customer regulations, risking penalties, legal action or prison.

Service Reaction and Content Elimination

Based on TikTok, the platform has taken down problematic content and prohibited related hashtags and query recommendations. The organization stated it was dedicated to maintaining the platform secure and allocating resources in strengthening compliance measures.

Digital Trading Operations

Investigations also found communities with up to nine thousand members selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up groups with thousands of members, filled with images of slimming results, positive testimonials and step-by-step guides for mixing or injecting at home.

After minutes of joining one group, a seller shared WhatsApp details, where the majority of transactions occur. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.

Product Details and Pricing

Within these communities, messages show dark colored packages with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with sterile water, or pre-filled pens usually sold at 160 pounds for 20mg. When questioned how much time a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service said it actively moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they cannot confirm. Although the research behind this drug is sound, these digital versions may not include what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake treatments are highly risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has already encountered individuals harmed by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company experimental product not yet approved … may expose users to potentially significant medical dangers”.